|1.||Studneva, I M: 6 articles (06/2014 - 01/2010)|
|2.||Pisarenko, O I: 6 articles (06/2014 - 01/2010)|
|3.||Pal'keeva, M E: 5 articles (01/2013 - 01/2010)|
|4.||Az'muko, A A: 5 articles (01/2013 - 01/2010)|
|5.||Sidorova, M V: 5 articles (01/2013 - 01/2010)|
|6.||Bespalova, Zh D: 5 articles (01/2013 - 01/2010)|
|7.||Tskitishvili, O V: 4 articles (06/2014 - 11/2011)|
|8.||Serebryakova, L I: 3 articles (06/2014 - 11/2011)|
|9.||Pelogeykina, Yu A: 3 articles (06/2014 - 11/2011)|
|10.||Pelogeĭkina, Iu A: 3 articles (01/2013 - 01/2010)|
|1.||Myocardial Ischemia (Ischemic Heart Diseases)
11/01/2015 - "Exogenously administered chemically modified apelin-12 (MA) has been shown to exhibit protective effects in myocardial ischemia/reperfusion (I/R) injury. "
06/01/2014 - "Apelin-12 and its structural analog enhance antioxidant defense in experimental myocardial ischemia and reperfusion."
06/01/2014 - "This study investigated the effects of peptide apelin-12 (H-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH, A12) and its novel structural analog (H-(N(α)Me)Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Nle-Pro-Phe-OH, AI) on myocardial antioxidant enzyme activities, lipid peroxidation, and reactive oxygen species formation in ex vivo and in vivo models of myocardial ischemia/reperfusion (I/R) injury. "
01/01/2013 - "Effects of apelin-12 H-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH (A12) and its modified analogue H-(NMe)Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Nle-Pro-Phe-OH (I) on activity of antioxidant enzymes, formation of malonic dialdehyde (MDA) and generation of reactive oxygen species (ROS) were studied in ex vivo and in vivo models of myocardial ischemia and reperfusion (I/R) injury in Wistar rats. "
06/01/2014 - "We aimed to investigate, circulating vaspin, apelin-12 and apelin-36 levels in subjects with metabolic syndrome (MetS) and also to search for the association of vaspin and apelin levels with insulin resistance (IR), high sensitivity C-reactive protein (HsCRP), Carotid Artery Intima-Media Thickness (CIMT) and cardiovascular risk factors. "
01/01/2014 - "To investigate possible correlations between apelin-12 levels and obesity in children in China and associations between apelin-12 and obesity-related markers, including lipids, insulin sensitivity and insulin resistance index (HOMA-IR). "
08/01/2013 - "The aim of the study was to analyse relationships between plasma apelin-36 and apelin-12 levels, nutritional status, insulin resistance and hormonal disturbances, as well as plasma adiponectin, leptin and resistin concentrations in PCOS women. "
|4.||Hypertension (High Blood Pressure)
05/14/2014 - "The present study tests the dose-dependence of the effect of ethanol leaf extracts on hypertension and on biomarkers associated with blood pressure control, such as angiotensin-II (AII), plasma renin activity (PRA), apelin-12 (A), endothelin (ET) and nitric oxide (NO), compared to captopril. "
01/01/2013 - "[Antioxidant properties of apelin-12 and its structural analogue in experimental ischemia and reperfusion]."
01/01/2010 - "[Effects of exogenous apelin-12 on functional and metabolic recovery of isolated rat heart after ischemia]."
07/01/2013 - "To examine cardioprotective effects of Ρ-terminal fragment of adipokine apelin-12 (A12), its novel structural analogue [MeArg(1), NLe(10)]-A12 (I), and [d-Ala(12)]-A12 (II), a putative antagonist of APJ receptor, employing in vivo model of ischemia/reperfusion (I/R) injury. "
11/01/2012 - "Effects of apelin-12 (a peptide comprised of 12 aminoacids, A-12) on recovery of energy metabolism and cardiac function were studied in isolated working rat hearts perfused with Krebs buffer (KB) containing 11 mM glucose that were subjected to global ischemia and reperfusion. "
|1.||Reactive Oxygen Species (Oxygen Radicals)
|10.||Biological Markers (Surrogate Marker)